Company · CIK 0001228627 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Opus Genetics, Inc. · IRD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 FMForm 4 → | Sep 11, 4:09 pm EDT | George MagrathChief Executive Officer, Director | 467,698 | $1.93 | $901,960 | 2,048,485 | — | |
| Sep 8, 2026 MForm 4 → | Sep 8, 4:05 pm EDT | Cam GallagherDirector | 784,314 | $1.15 | $901,961 | 2,800,111 | — | |
| Sep 3, 2026 SForm 4 → | Sep 8, 4:05 pm EDT | Robert E. GagnonChief Financial Officer | 28,000 | $4.54 | $127,212 | 556,375 | −4.79% | |
| Jul 23, 2026 SForm 4 → | Jul 27, 4:08 pm EDT | Benjamin R YerxaPresident, Director | 7,429 | $2.97 | $22,064 | 704,106 | −1.04% | |
| Jul 23, 2026 SForm 4 → | Jul 27, 4:07 pm EDT | Joseph K SchachleChief Operating Officer | 4,644 | $2.94 | $13,653 | 291,440 | −1.57% | |
| Jul 23, 2026 SForm 4 → | Jul 27, 4:07 pm EDT | George MagrathChief Executive Officer, Director | 9,475 | $2.95 | $27,926 | 1,731,869 | −0.54% | |
| Jul 23, 2026 SForm 4 → | Jul 27, 4:06 pm EDT | Robert E. GagnonChief Financial Officer | 7,783 | $2.95 | $22,942 | 584,375 | −1.31% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 MForm 4 → | Sep 11, 4:09 pm EDT | George MagrathChief Executive Officer, Director | 392,157 | — | — | 0 | — | |
| Sep 8, 2026 MForm 4 → | Sep 8, 4:05 pm EDT | Cam GallagherDirector | 784,314 | — | — | 0 | — |